The 1975 International Conference on Recombinant DNA Molecules held at the Asilomar Conference Center in California has cast a long shadow. Groundbreaking at the time, the meeting of scientists to ...
A paradigm shift in molecular biology has set in. It is now possible to email a DNA sequence to a company and receive a recombinant plasmid vector of choice. We are soon heading into an era where ...
In 1986, the Recombivax HB vaccine for hepatitis B was approved for human use in several countries, the culmination of research started by William Rutter, Pablo Valenzuela and colleagues in 1979 on ...
Gene editing was a new idea in the mid-1970s. So when two of America's most prestigious research institutions planned a new facility for work in recombinant DNA, the technology that lets scientists ...
Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...
The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...
A group of 18 scientists and ethicists today warned that a revolutionary new tool to cut and splice DNA should be used cautiously when attempting to fix human genetic disease, and strongly discouraged ...
Researchers at the USC School of Pharmacy indicate that recombinant DNA technology may allow for oral administration of drugs that previously could only be given by injection. LOS ANGELES, May 6 - ...
Cells are constantly subjected to DNA damage from a range of internal and environmental sources. It is estimated that cells can experience as many as 100,000 DNA lesions per day. One of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback